https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-compensation-arrangement-with-individual-allocated-share-based-compensation-expense https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-compensation-arrangement-with-individual-compensation-expense https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-not-subject-to-expiration https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/deferred-tax-liabilities-deferred-expense https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/dividends-common-stock-cash https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/number-of-reportable-segments https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-lease-cost https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/other-current-assets https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/other-nonoperating-expense https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/other-nonoperating-income https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/paid-in-capital-income-tax-deficiency-from-share-based-compensation https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/payments-for-proceeds-from-investments https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/proceeds-from-issuance-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/proceeds-from-sale-maturity-and-collections-of-investments https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/restricted-cash https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/restricted-stock-shares-issued-net-of-shares-for-tax-withholdings https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/security-deposit https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/short-term-lease-cost https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/theseus-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted